对乙酰氨基酚试剂市场基于(主要地区、市场参与者、规模和份额)- 预测至 2028 年

  • Report Code : TIPRE00026173
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 172
Buy Now

Acetaminophen Reagents Market Size & Growth | Report by 2028

Buy Now

 

乙酰氨基酚试剂市场规模预计将从 2021 年的 5.3956 亿美元增至 2028 年的 7.5039 亿美元;预计 2021 年至 2028 年的复合年增长率为 4.8%。



乙酰氨基酚(对乙酰氨基酚)是全球常用的止痛药和退热药。乙酰氨基酚试剂是一种药物检测试剂,用于确定血液样本中乙酰氨基酚的含量是否过量。该试剂还用于评估药物水平,是治疗和剂量管理严重肾衰竭患者的重要指标。药物过量发生率高和采用乙酰氨基酚检测等因素推动了市场增长。然而,注意力缺陷多动障碍 (ADHD) 和其他妊娠并发症风险的增加限制了市场的增长。此外,在预测期内,市场中关键参与者有限,预计将为市场参与者提供巨大的增长机会,以扩大其客户群,尤其是在发展中国家。

定制研究以满足您的需求

我们可以优化和定制标准产品无法满足的分析和范围。这种灵活性将帮助您获得业务规划和决策所需的准确信息。

对乙酰氨基酚试剂市场:

对乙酰氨基酚试剂市场

  • 复合年增长率(2021 - 2028 年)
    4.8%
  • 2021 年市场规模
    5.3956 亿美元
  • 2028 年市场规模
    7.5039 亿美元

市场动态

增长动力
  • 財政部
  • 財政部
  • 財政部
未来的趋势
  • 財政部
  • 財政部
  • 財政部
机会
  • 財政部
  • 財政部
  • 財政部

关键人物;主力;重要一员

  •  
  • Biorbyt 有限公司
  • 赛默飞世尔科技公司
  • 西门子医疗股份公司
  • 雅培
  • 积水诊断
  • 贝克曼库尔特公司
  • 朗道实验室有限公司
  • 美国筛查有限公司
  • EKF 诊断

区域概况

  • 北美
  • 欧洲
  • 亚太
  • 南美洲和中美洲
  • 中东和非洲

市场细分

产品
  • 抗体/底物试剂
  • 酶试剂
  • 对乙酰氨基酚抗血清
  • 对乙酰氨基酚荧光素示踪剂
  • 预处理溶液
应用
  • 酶促分析和免疫分析
最终用户
  • 医院
  • 诊断实验室
  • POC 测试
  • 法医实验室
  • 其他的
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

COVID-19 疫情的全球影响已波及多个市场。尽管医疗保健行业在过去几年中见证了许多病毒的爆发,例如 SARS 和 H1N1,但 SARS-CoV-2 的严重性由于其传播方式而使情况变得复杂。北美是采用和发展新技术的最重要地区之一,因为北美政府出台了促进创新的优厚政策、庞大的工业基础和高购买力,主要是在美国和加拿大等发达国家。因此,对行业运营的任何影响都会影响该地区的经济增长。自疫情爆发以来,北美的 COVID-19 病例数量不断增加。例如,根据 Worldometer 的数据,截至 2021 年 12 月 1 日,病例数达到 61,124,468 例,死亡人数为 1,218,505 人,而仅美国就报告了 823,390 人死亡。墨西哥和加拿大也受到了类似的影响。结果,医疗保健系统不堪重负,为所有患者提供医疗服务成为该地区的一项挑战,感染人数的突然激增导致紧急医疗用品短缺。为了控制疫情,政府采取了预防措施,例如全国封锁和社会疏离政策。此外,制药和医疗器械行业也面临着疫情的负面影响。随着 COVID-19 疫情的持续蔓延,这些公司在管理运营方面面临困难。美国许多对乙酰氨基酚试剂公司受到严重影响,原因是公司分销产品的能力受到干扰和限制,以及设施暂时关闭。此外,市场参与者的业务运营也受到干扰。此外,产品需求下滑对北美对乙酰氨基酚试剂市场产生了轻微的负面影响

 

市场洞察

药物过量发生率高推动对乙酰氨基酚试剂市场增长

对乙酰氨基酚是一种常用的口服退热镇痛药,在以适当的治疗剂量服用时具有出色的安全性。它是一种非处方 (OTC) 药物,随处可见。对乙酰氨基酚存在于许多产品中,因此人们低估了它的毒性。各种非处方感冒和流感药物都含有对乙酰氨基酚。成人对乙酰氨基酚的一般剂量为每天最多 3,000 毫克单一成分对乙酰氨基酚,65 岁及以上患者则少于 3,000 毫克。患者会摄入过量的药物,因为他们误解了剂量说明或无法识别他们正在使用的多种药物中是否含有对乙酰氨基酚。服用超过规定剂量的药物,尤其是 7,000 毫克或更多,可能会导致严重的过量问题,例如急性肝功能衰竭或致命。如果一个人在同一时期服用了不止一种含有对乙酰氨基酚的非处方药,血液中可能会检测到危险的高剂量对乙酰氨基酚,这可能会损害肝脏。如果患者有肝脏或肾脏疾病史,那么使用此药之前需要先与医疗保健提供者讨论。

对乙酰氨基酚过量服用是导致药物过量引起的急性肝功能衰竭和死亡的主要原因之一。如果肝脏损伤严重,可能需要进行肝脏移植才能挽救患者的生命。在出现肝功能衰竭后,三分之一的患者都需要肝移植。根据《大规模对乙酰氨基酚过量服用》的报告,对乙酰氨基酚中毒导致的肝移植病例占美国所有肝移植病例的近一半。在美国,每年因对乙酰氨基酚过量服用而就诊的病例有 56,000 例,住院病例有 26,000 例。对全国死亡档案的分析显示,每年因同样原因死亡的病例有 458 例,其中 100 例几乎是无意的。在加拿大,每年因对乙酰氨基酚过量服用而住院的病例有近 4,500 例,其中 700 例是无意的。因此,随着对乙酰氨基酚过量用药的发生率以及住院和急诊室就诊人数的增加,降低对乙酰氨基酚药物强度和患者剂量管理的需求也随之增加,这推动了对精确检测以确定药物水平的需求。提高对乙酰氨基酚测试的准确性有利于对乙酰氨基酚试剂市场的增长。

 

基于产品的洞察

根据产品,全球对乙酰氨基酚试剂市场细分为抗体/底物试剂、酶试剂、对乙酰氨基酚抗血清、对乙酰氨基酚荧光素示踪剂和预处理溶液。2021 年,抗体/底物试剂部分占据了最大的市场份额。抗体/底物试剂是进行对乙酰氨基酚测试的主要化学试剂。全球对乙酰氨基酚试剂市场上的多家公司都提供这些试剂。例如,Beckman Coulter, Inc. 在其 Emit tox 对乙酰氨基酚测定中提供抗体/底物试剂 (OSR7A568 R1),用于定量分析人血清或血浆中的对乙酰氨基酚。

 

基于应用的洞察

 

根据应用,对乙酰氨基酚试剂市场分为酶测定和免疫测定。2021 年,酶测定部分占据了更大的市场份额。此外,预计免疫测定部分在 2021 年至 2028 年期间的复合年增长率会更高。

 

对乙酰氨基酚试剂市场报告范围

报告属性细节
2021 年市场规模5.3956亿美元
2028 年市场规模7.5039亿美元
全球复合年增长率(2021 - 2028)4.8%
历史数据2019-2020
预测期2022-2028
涵盖的领域按产品
  • 抗体/底物试剂
  • 酶试剂
  • 对乙酰氨基酚抗血清
  • 对乙酰氨基酚荧光素示踪剂
  • 预处理溶液
按应用
  • 酶促分析和免疫分析
按最终用户
  • 医院
  • 诊断实验室
  • POC 测试
  • 法医实验室
  • 其他的
覆盖地区和国家北美
  • 我们
  • 加拿大
  • 墨西哥
欧洲
  • 英国
  • 德国
  • 法国
  • 俄罗斯
  • 意大利
  • 欧洲其他地区
亚太
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 亚太其他地区
南美洲和中美洲
  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区
中东和非洲
  • 南非
  • 沙特阿拉伯
  • 阿联酋
  • 中东和非洲其他地区
市场领导者和主要公司简介
  •  
  • Biorbyt 有限公司
  • 赛默飞世尔科技公司
  • 西门子医疗股份公司
  • 雅培
  • 积水诊断
  • 贝克曼库尔特公司
  • 朗道实验室有限公司
  • 美国筛查有限公司
  • EKF 诊断
  • 示例 PDF 通过定性和定量分析展示了内容结构和信息的性质。

 

 

基于最终用户的洞察

 

根据最终用户,对乙酰氨基酚试剂市场分为医院、诊断实验室、POC 检测、法医实验室等。医院部门在 2021 年占据了最大的市场份额。此外,预计诊断实验室部门在预测期内将实现最高的复合年增长率。

在对乙酰氨基酚试剂市场运营的公司采用治疗创新策略来满足全球不断变化的客户需求,这也使他们能够在全球市场上保持自己的品牌名称。

报告将对乙酰氨基酚试剂市场细分如下:

根据产品,对乙酰氨基酚试剂市场细分为抗体/底物试剂、酶试剂、对乙酰氨基酚抗血清、对乙酰氨基酚荧光素示踪剂和预处理溶液。根据应用,市场分为酶测定和免疫测定。根据最终用户,市场细分为医院、诊断实验室、POC 测试、法医实验室等。按地域划分,全球对乙酰氨基酚试剂市场细分为北美、欧洲、亚太地区、南美和中美以及中东和非洲。北美市场进一步细分为美国、加拿大和墨西哥。欧洲对乙酰氨基酚试剂市场细分为英国、德国、法国、意大利、西班牙和欧洲其他地区。亚太地区的对乙酰氨基酚试剂市场进一步细分为日本、中国、印度、韩国、澳大利亚和亚太其他地区。南美和中美市场细分为巴西、阿根廷和南美和中美其他地区。中东和非洲对乙酰氨基酚试剂市场进一步细分为阿联酋、沙特阿拉伯、南非和中东和非洲其他地区。

 

公司简介

Biorbyt Ltd.、Thermo Fisher Scientific Inc.、Siemens Healthineers AG、Abbott、Sekisui Diagnostics、Beckman Coulter, Inc.、Randox Laboratories, Ltd.、American Screening Corporation, Inc.、EKF Diagnostics 和 Bio-Rad Laboratories Inc. 是市场上领先的公司。

Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


What is the COVID 19 impact on the Acetaminophen reagents market in the coming years?

The global impacts of COVID-19 are being felt across several markets. Although the healthcare sector had witnessed SARS, H1N1, and other outbreaks in the last few years, the severity of the COVID-19 has made the situation more complicated due to its mode of transmission. The acetaminophen reagents market witnessed a shortfall at the beginning of the COVID-19 crisis due to disruption in the supply chain and slumped demand due to the lockdown announced by most the countries that caused disruptions in manufacturing and operations in the pharmaceutical sector. Additionally, appointments and operations have been delayed in many clinics around the world due to increasing cases, as approximately 40% of the diagnosed COVID-19 cases required hospitalization; and some critical cases were admitted to intensive care units (ICU). With the number of rising cases, there was a significant decrease in procedures due to a lack of healthcare resources. It also impacted the new product launches, impacting sales and growth of the market in the region. Moreover, market players also witnessed disruption in their business operations, slumped demand for products had a marginally negative impact on the acetaminophen reagents market.

Which region is expected to witness significant demand for the acetaminophen reagents market in the coming years?

Global acetaminophen reagents market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for acetaminophen reagents. The growth of the market in countries such as the US and Canada is driven by the factors such as increased adoption of acetaminophen testing and product penetration. Additionally, progression in toxicity testing and critical care facilities raised awareness regarding the over usage of OTC drugs, increased awareness of drug-induced toxicity and more stringent government rules are some of the prominent factors propelling the market growth in North America. Therefore, the region holds huge potential for the acetaminophen reagents market players to grow during the forecast period

Which are the top companies that hold the market share in acetaminophen reagents market?

Sekisui Diagnostics and Beckman Coulter, Inc. are the top two companies that hold huge market shares in the acetaminophen reagents market

Which application held the largest share in the acetaminophen reagents market?

The enzymatic assays segment dominated the global Acetaminophen reagents market and accounted for the largest market share of 56.69% in 2021.

Which end user held the largest share in the acetaminophen reagents market?

The hospital segment dominated the global Acetaminophen reagents market and held the largest market share of 31.81% in 2021.

Who are the key players in the acetaminophen reagents market?

The acetaminophen reagents market majorly consists of players such Biorbyt Ltd., Thermo Fisher Scientific Inc., Siemens Healthineers AG, Abbott, Sekisui Diagnostics, Beckman Coulter, Inc., Randox Laboratories, Ltd., American Screening Corporation, Inc., EKF Diagnostics, Bio-Rad Laboratories Inc., amongst others.

What is an acetaminophen reagent?

Acetaminophen is a p-aminophenol derivative that functions as an analgesic and antipyretic. Acetaminophen (paracetamol) is the commonly used analgesic globally. Acetaminophen reagents are drug testing reagents that are used to determine the presence of an excessive amount of acetaminophen in a blood sample. Acetaminophen reagents are also used to assess drug levels and are an essential metric in the treatment and dose management of patients with severe renal failure.

What are the driving factors for the acetaminophen reagents market across the globe?

Key factors that are driving the growth of this market are the high incidence of drugs overdose and adoption of acetaminophen testing are expected to boost the market growth for the acetaminophen reagents over the years

What is the market CAGR value of the acetaminophen reagents market during the forecast period?

The CAGR value of the acetaminophen reagents market during the forecasted period of 2021-2028 is 4.8%.

Which product led the acetaminophen reagents market?

The antibody/substrate reagent segment held the largest share of the market in the global acetaminophen reagents market and held the largest market share of 29.88% in 2021.

The List of Companies - Acetaminophen Reagents Market

  1. Biorbyt Ltd.            
  2. Thermo Fisher Scientific Inc.          
  3. Siemens Healthineers AG               
  4. Abbott     
  5. Sekisui Diagnostics             
  6. Beckman Coulter, Inc.       
  7. Randox Laboratories, Ltd.               
  8. American Screening Corporation, Inc.   
  9. EKF Diagnostics    
  10. Bio-Rad Laboratories Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports